Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa
Cancers · 24.06.2025 · 17 (13) · 2113
DOI: 10.3390/cancers17132113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 24.06.2025. Verfasst von Amine Souadka und 13 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Department, National Institute of Oncology, Mohammed V University, Rabat 10000, Morocco. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Cancer Research Institute IRC”, Kingdom of Morocco.
Abstract (Originalsprache)
Background
Peritoneal surface malignancies (PSM) are aggressive cancers with limited treatment access in low- and middle-income countries (LMICs). While cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have improved survival outcomes globally, their feasibility in LMICs remains underexplored. This first multicenter study in North Africa evaluates the implementation and outcomes of CRS with or without HIPEC in resource-limited settings.
Methods
A retrospective cohort study of 391 patients with PSM (colorectal cancer, pseudomyxoma peritonei, ovarian cancer, gastric cancer, or mesothelioma) treated with CRS ± HIPEC between 2014 and 2020 at four tertiary centers in Morocco, Tunisia, and Algeria. Primary outcomes included overall survival (OS), disease-free survival (DFS), and severe postoperative morbidity (Clavien-Dindo ≥ IIIa). Cox regression was used to identify independent prognostic factors.
Results
Among 391 patients, complete cytoreduction (CC-0/1) was achieved in 88%, and HIPEC was performed in 39%. Severe morbidity occurred in 22%, with HIPEC, spleno-pancreatectomy, and incomplete cytoreduction (CC-2) identified as significant risk factors. The median OS was 68 months, with 1- and 5-year survival rates of 97% and 56%, respectively. Patients undergoing CRS + HIPEC had significantly longer OS than CRS alone (70 vs. 64 months, p = 0.016), though DFS was not significantly different between groups. Independent predictors of improved OS included HIPEC, CC score, PCI, and primary tumor type.
Conclusions
This first North African multicenter study establishes the feasibility and efficacy of CRS and HIPEC in LMICs, achieving survival outcomes comparable to high-income settings. The findings support expanding advanced PSM treatment programs in resource-limited settings, emphasizing structured training and multidisciplinary collaboration to improve access and outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surgical Oncology Department, National Institute of Oncology, Mohammed V University, Rabat 10000, Morocco.
- Surgical Department A, Rabta Hospital, Tunis 1007, Tunisia.
- Surgical Oncology Department, Batna Cancer Institute, Batna, Algeria.
- Medical Oncology Department, Salah-Azaiz Institute, Tunis 1006, Tunisia.
- Surgical Oncology Department, Private Oncology Center, Rabat, Morocco.
ORCID-Profile: Zakaria El Mouatassim, Mohammed Anass Majbar
Förderung
- “Cancer Research Institute IRC”, Kingdom of Morocco
Zitieren
APA
Souadka, A., Habbat, H., Makni, A., Abid, M., El Mouatassim, Z., Daghfous, A., Korjani, Z., Rebai, W., Ayadi, M., Messai, W. H., Majbar, M. A., Benkabbou, A., Mohsine, R., & Souadka, A. (2025). Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa. Cancers, 17(13), 2113. https://doi.org/10.3390/cancers17132113
Vancouver
Souadka A, Habbat H, Makni A, Abid M, El Mouatassim Z, Daghfous A, et al. Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa. Cancers. 2025;17(13):2113. doi:10.3390/cancers17132113
BibTeX
@article{Souadka2025,
author = {Souadka, Amine and Habbat, Hajar and Makni, Amin and Abid, Mourad and El Mouatassim, Zakaria and Daghfous, Amin and Korjani, Zakia and Rebai, Wael and Ayadi, Mouna and Messai, Wafa Hania and Majbar, Mohammed Anass and Benkabbou, Amine and Mohsine, Raouf and Souadka, Abdelilah},
title = {Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa},
journal = {Cancers},
year = {2025},
volume = {17},
number = {13},
pages = {2113},
doi = {10.3390/cancers17132113}
}
EUVIMED